Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 41Leukemia, Myeloid, Acute 35Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Lymphoma, Non-Hodgkin 21Leukemia 19Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 17Myeloproliferative Disorders 13Multiple Myeloma 13Lymphoma 13Primary Myelofibrosis 12Hematologic Neoplasms 11Leukemia, Myelomonocytic, Juvenile 9Graft vs Host Disease 8Leukemia, Myelomonocytic, Chronic 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Leukemia, Neutrophilic, Chronic 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Blast Crisis 4Recurrence 3

Interventions

Therapeutics 5Flow Cytometry 4Methylprednisolone 3liposomal amphotericin B 2Psychiatric Rehabilitation 2Prednisone 2Polymerase Chain Reaction 2Ondansetron 2Itraconazole 2Ipilimumab 2Immunologic Techniques 2Immunoenzyme Techniques 2Dexamethasone 2Cyclophosphamide 2Caspofungin 2Calcium Dobesilate 2CTLA-4 Antigen 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2thymoglobulin 1sargramostim 1dexamethasone acetate 1dexamethasone 21-phosphate 1aldesleukin 1Vorinostat 1Voriconazole 1Valacyclovir 1Tacrolimus 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × thymoglobulin × Myeloid × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡